Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Mathieu

Showing results (51-60 of 625) with videos related to

Pageof 63
Sort By:
Diabetologia|May 17, 2024
2024: The year to take European action on diabetes to the next levelStefano Del Prato, Bart Torbeyns, Chantal Mathieu, et al.
Diabetes Technology & Therapeutics|February 14, 2022
Diabetic Ketoacidosis After Sodium-Glucose Cotransporter Inhibitor Initiation Under Advanced Hybrid Closed-Loop Therapy in Type 1 DiabetesMargaretha M Visser, Chantal Mathieu, Pieter Gillard
Proteomics. Clinical Applications|December 8, 2010
Understanding dendritic cell biology and its role in immunological disorders through proteomic profilingGabriela Bomfim Ferreira, Chantal Mathieu, Lut Overbergh
Expert Opinion on Biological Therapy|March 10, 2017
Prospects of a type 1 diabetes vaccineDana P Cook, Conny Gysemans, Chantal Mathieu
Nature Reviews. Endocrinology|August 18, 2021
One hundred years of insulin therapyChantal Mathieu, Pieter-Jan Martens, Roman Vangoitsenhoven
Frontiers in Immunology|February 2, 2018
<i>Lactococcus lactis</i> As a Versatile Vehicle for Tolerogenic ImmunotherapyDana P Cook, Conny Gysemans, Chantal Mathieu
Diabetes, Obesity & Metabolism|March 10, 2026
Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney diseaseAmy K Mottl, Kamlesh Khunti, Chantal Mathieu
Expert Review of Proteomics|June 27, 2017
Understanding type 1 diabetes through proteomicsInne Crèvecoeur, Saurabh Vig, Chantal Mathieu, et al.
Rheumatic Diseases Clinics of North America|April 25, 2012
Vitamin D and diabetesTatiana Takiishi, Conny Gysemans, Roger Bouillon, et al.
Kidney International|February 26, 2010
Vitamin D: a pleiotropic hormoneAnnemieke Verstuyf, Geert Carmeliet, Roger Bouillon, et al.
Pageof 63

Showing results (51-60 of 625) with videos related to

Sort By:
Pageof 63
Diabetologia|May 17, 2024
2024: The year to take European action on diabetes to the next levelStefano Del Prato, Bart Torbeyns, Chantal Mathieu, et al.
Diabetes Technology & Therapeutics|February 14, 2022
Diabetic Ketoacidosis After Sodium-Glucose Cotransporter Inhibitor Initiation Under Advanced Hybrid Closed-Loop Therapy in Type 1 DiabetesMargaretha M Visser, Chantal Mathieu, Pieter Gillard
Proteomics. Clinical Applications|December 8, 2010
Understanding dendritic cell biology and its role in immunological disorders through proteomic profilingGabriela Bomfim Ferreira, Chantal Mathieu, Lut Overbergh
Expert Opinion on Biological Therapy|March 10, 2017
Prospects of a type 1 diabetes vaccineDana P Cook, Conny Gysemans, Chantal Mathieu
Nature Reviews. Endocrinology|August 18, 2021
One hundred years of insulin therapyChantal Mathieu, Pieter-Jan Martens, Roman Vangoitsenhoven
Frontiers in Immunology|February 2, 2018
<i>Lactococcus lactis</i> As a Versatile Vehicle for Tolerogenic ImmunotherapyDana P Cook, Conny Gysemans, Chantal Mathieu
Diabetes, Obesity & Metabolism|March 10, 2026
Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney diseaseAmy K Mottl, Kamlesh Khunti, Chantal Mathieu
Expert Review of Proteomics|June 27, 2017
Understanding type 1 diabetes through proteomicsInne Crèvecoeur, Saurabh Vig, Chantal Mathieu, et al.
Rheumatic Diseases Clinics of North America|April 25, 2012
Vitamin D and diabetesTatiana Takiishi, Conny Gysemans, Roger Bouillon, et al.
Kidney International|February 26, 2010
Vitamin D: a pleiotropic hormoneAnnemieke Verstuyf, Geert Carmeliet, Roger Bouillon, et al.
Pageof 63